De novo drug design is a computational and theoretical methodology focused on generating novel chemical entities with predicted affinity and activity towards a specific biological target, constructing potential drug molecules atom-by-atom or fragment-by-fragment based on design principles, often derived from target structure or desired properties. This approach aims to discover entirely new molecular scaffolds and side chains optimized for therapeutic intervention, distinct from modifying known lead compounds.